Institut National De La Sant Et De La Recherche Mdicale competitive analysis

Explore Institut National De La Sant Et De La Recherche Mdicale's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
Sep 3, 2025Use Of Ahr Agonist For The Preventive Or Curative Treatment Of Metabolic Syndrome And The Associated Disorders1
Apr 3, 2024Aav-Mediated Gene Therapy Restoring The Otoferlin Gene5
Nov 23, 2022Method For Treating Checkpoint Inhibitors Induced Adverse Events1
Feb 23, 2022Nucleic Acid Vector Tablets1
Oct 6, 2021Il-15 And Il-15Raplha Sushi Domain Based Modulokines2
Mar 31, 2021Monoclonal Antibodies That Bind B7H6 And Uses Thereof1
Dec 9, 2020Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange Chromatography1
Nov 18, 2020Methods For Producing A Population Of Pancreatic Beta-Cells1
Mar 11, 2020Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)1
Jul 11, 2018Il-15 And Il-15Raplha Sushi Domain Based Modulokines1

Latest PTAB cases involving Institut National De La Sant Et De La Recherche Mdicale

Discover the latest PTAB cases involving Institut National De La Sant Et De La Recherche Mdicale, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Institut National De La Sant Et De La Recherche Mdicale with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE - 4 - -
FUCHS1 - - 4
JAMES POOLE204 - - -
JANSSEN BIOTECH151916